The pharmaceutical industry can and should reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions.
Local Note
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America